|
US5545223A
(en)
*
|
1990-10-31 |
1996-08-13 |
Baxter International, Inc. |
Ported tissue implant systems and methods of using same
|
|
US5713888A
(en)
*
|
1990-10-31 |
1998-02-03 |
Baxter International, Inc. |
Tissue implant systems
|
|
JP3508023B2
(ja)
*
|
1990-10-31 |
2004-03-22 |
バクスター、インターナショナル、インコーポレイテッド |
密接血管化埋め込み材料
|
|
KR950007873A
(ko)
*
|
1993-09-20 |
1995-04-15 |
후꾸하라 요시하루 |
생리 활성 물질 지속 방출형의 의약 제제
|
|
JPH08503715A
(ja)
*
|
1993-09-24 |
1996-04-23 |
バクスター、インターナショナル、インコーポレイテッド |
埋め込み装置の血管化を促進するための方法
|
|
US5672357A
(en)
*
|
1994-07-01 |
1997-09-30 |
Monsanto Company |
Method and device for implantation of large diameter objects in bovines
|
|
US5595752A
(en)
*
|
1994-07-01 |
1997-01-21 |
Monsanto Company |
Increasing dressing percentage and carcass weight in finishing beef cattle
|
|
US6156305A
(en)
*
|
1994-07-08 |
2000-12-05 |
Baxter International Inc. |
Implanted tumor cells for the prevention and treatment of cancer
|
|
US5837276A
(en)
*
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
|
US6060640A
(en)
*
|
1995-05-19 |
2000-05-09 |
Baxter International Inc. |
Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
CN100493647C
(zh)
*
|
1996-02-02 |
2009-06-03 |
精达制药公司 |
利用可植入系统持续释放活性物质
|
|
US6156331A
(en)
*
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6395292B2
(en)
*
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6132420A
(en)
*
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
WO1998020930A1
(en)
|
1996-11-15 |
1998-05-22 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
EP0949905B1
(en)
*
|
1996-12-20 |
2001-07-18 |
Alza Corporation |
Injectable depot gel composition and method of preparing the composition
|
|
ATE223208T1
(de)
|
1997-12-22 |
2002-09-15 |
Alza Corp |
Membranen zur steuerung des durchflusses in vorrichtungen mit kontrollierter wirkstoffabgabe
|
|
US7890176B2
(en)
*
|
1998-07-06 |
2011-02-15 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating chronic pelvic pain
|
|
AU775904B2
(en)
*
|
1999-02-08 |
2004-08-19 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
EP1135052A1
(en)
*
|
1999-02-12 |
2001-09-26 |
Cygnus, Inc. |
Devices and methods for frequent measurement of an analyte present in a biological system
|
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
|
WO2002043800A2
(en)
*
|
2000-11-29 |
2002-06-06 |
Durect Corporation |
Devices and methods for controlled delivery from a drug delivery device
|
|
AU779277B2
(en)
*
|
1999-06-04 |
2005-01-13 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6582441B1
(en)
|
2000-02-24 |
2003-06-24 |
Advanced Bionics Corporation |
Surgical insertion tool
|
|
AU2001245513A1
(en)
*
|
2000-03-06 |
2001-09-17 |
Kumarpal A. Shah |
Method for immune switching
|
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
AU8206401A
(en)
|
2000-08-03 |
2002-02-18 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
KR20040007413A
(ko)
*
|
2000-11-03 |
2004-01-24 |
바이오메디신즈 인코포레이티드 |
단기 및 장기 약물 약량측정 방법
|
|
ES2250504T3
(es)
*
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
|
US20060064140A1
(en)
*
|
2001-01-30 |
2006-03-23 |
Whitehurst Todd K |
Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
|
|
US7493172B2
(en)
*
|
2001-01-30 |
2009-02-17 |
Boston Scientific Neuromodulation Corp. |
Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
|
|
US20050143789A1
(en)
*
|
2001-01-30 |
2005-06-30 |
Whitehurst Todd K. |
Methods and systems for stimulating a peripheral nerve to treat chronic pain
|
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
|
KR20040053291A
(ko)
*
|
2001-11-09 |
2004-06-23 |
바이오메디신즈 인코포레이티드 |
오메가 인터페론을 이용한 질환 치료 방법
|
|
NZ533435A
(en)
*
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
|
MXPA04004665A
(es)
|
2001-11-14 |
2004-09-10 |
Alza Corp |
Composiciones de deposito inyectable y uso de los mismos.
|
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
|
WO2003041685A1
(en)
*
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Injectable depot composition
|
|
JP2005522241A
(ja)
*
|
2002-03-11 |
2005-07-28 |
アルコン，インコーポレイテッド |
移植可能な薬物送達システム
|
|
EP1702561B1
(en)
|
2002-03-22 |
2011-05-04 |
Animas Technologies LLC |
Improving performance for an analyte monitoring device
|
|
US7620451B2
(en)
|
2005-12-29 |
2009-11-17 |
Ardian, Inc. |
Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
|
|
US9636174B2
(en)
|
2002-04-08 |
2017-05-02 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
|
US8347891B2
(en)
|
2002-04-08 |
2013-01-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
|
|
US8145316B2
(en)
|
2002-04-08 |
2012-03-27 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
|
US9308043B2
(en)
|
2002-04-08 |
2016-04-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
|
US20070135875A1
(en)
|
2002-04-08 |
2007-06-14 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
|
US7162303B2
(en)
|
2002-04-08 |
2007-01-09 |
Ardian, Inc. |
Renal nerve stimulation method and apparatus for treatment of patients
|
|
US20070129761A1
(en)
|
2002-04-08 |
2007-06-07 |
Ardian, Inc. |
Methods for treating heart arrhythmia
|
|
US8131371B2
(en)
|
2002-04-08 |
2012-03-06 |
Ardian, Inc. |
Methods and apparatus for monopolar renal neuromodulation
|
|
US8774922B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
|
|
US7853333B2
(en)
|
2002-04-08 |
2010-12-14 |
Ardian, Inc. |
Methods and apparatus for multi-vessel renal neuromodulation
|
|
US6978174B2
(en)
*
|
2002-04-08 |
2005-12-20 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
|
US8145317B2
(en)
|
2002-04-08 |
2012-03-27 |
Ardian, Inc. |
Methods for renal neuromodulation
|
|
US20140018880A1
(en)
|
2002-04-08 |
2014-01-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
|
US8150519B2
(en)
|
2002-04-08 |
2012-04-03 |
Ardian, Inc. |
Methods and apparatus for bilateral renal neuromodulation
|
|
US7653438B2
(en)
|
2002-04-08 |
2010-01-26 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
|
US7756583B2
(en)
|
2002-04-08 |
2010-07-13 |
Ardian, Inc. |
Methods and apparatus for intravascularly-induced neuromodulation
|
|
US9308044B2
(en)
|
2002-04-08 |
2016-04-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
|
US7617005B2
(en)
|
2002-04-08 |
2009-11-10 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
|
US20060206150A1
(en)
|
2002-04-08 |
2006-09-14 |
Ardian, Inc. |
Methods and apparatus for treating acute myocardial infarction
|
|
US20080213331A1
(en)
|
2002-04-08 |
2008-09-04 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
TWI353854B
(en)
|
2002-06-25 |
2011-12-11 |
Alza Corp |
Short duration depot formulations
|
|
US7254449B2
(en)
*
|
2002-07-31 |
2007-08-07 |
Advanced Bionics Corp |
Systems and methods for providing power to one or more implantable devices
|
|
NZ537955A
(en)
*
|
2002-07-31 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
|
AU2003256849A1
(en)
*
|
2002-07-31 |
2004-02-16 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
|
US20060009739A1
(en)
*
|
2002-09-06 |
2006-01-12 |
Durect Corporation |
Implantable flow regulator with failsafe mode and reserve drug supply
|
|
JP2006502158A
(ja)
|
2002-09-06 |
2006-01-19 |
デュレクト コーポレーション |
グルタメート媒介神経伝達のモジュレーターの内耳への送達
|
|
WO2004043432A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Alza Corporation |
Controlled release depot formulations
|
|
US7014636B2
(en)
*
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
WO2004089334A2
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
|
|
DE602004015755D1
(de)
*
|
2003-03-31 |
2008-09-25 |
Alza Corp |
Nicht wässrige einphasige visköse vehikel und formulierungen die diese vehikel verwenden
|
|
MXPA05010605A
(es)
|
2003-03-31 |
2005-11-23 |
Alza Corp |
Bomba osmotica con medios para disipar la presion interna.
|
|
US20070083240A1
(en)
*
|
2003-05-08 |
2007-04-12 |
Peterson David K L |
Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
|
|
EP1633317A4
(en)
|
2003-05-16 |
2008-08-20 |
Intermune Inc |
Synthetic chemokine receptor ligands and methods of use therefor
|
|
KR20060023140A
(ko)
*
|
2003-05-30 |
2006-03-13 |
알자 코포레이션 |
이식성 탄성중합체 데포 조성물, 이의 용도 및 이의제조방법
|
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
|
PL1670433T3
(pl)
|
2003-10-10 |
2013-03-29 |
Ferring Bv |
Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
|
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
|
US7769461B2
(en)
*
|
2003-12-19 |
2010-08-03 |
Boston Scientific Neuromodulation Corporation |
Skull-mounted electrical stimulation system and method for treating patients
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US7425340B2
(en)
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
|
US20050267555A1
(en)
|
2004-05-28 |
2005-12-01 |
Marnfeldt Goran N |
Engagement tool for implantable medical devices
|
|
US20060004185A1
(en)
*
|
2004-07-01 |
2006-01-05 |
Leese Richard A |
Peptide antibiotics and peptide intermediates for their prepartion
|
|
WO2006010013A1
(en)
*
|
2004-07-09 |
2006-01-26 |
Advanced Bionics Corporation |
Systems and methods for using a butterfly coil to communicate with or transfer power to an implantable medical device
|
|
EP2583717B1
(en)
|
2004-07-28 |
2019-02-20 |
Medtronic Ardian Luxembourg S.à.r.l. |
Methods and devices for renal nerve blocking
|
|
US8452407B2
(en)
*
|
2004-08-16 |
2013-05-28 |
Boston Scientific Neuromodulation Corporation |
Methods for treating gastrointestinal disorders
|
|
US20060095077A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Tronnes Carole A |
Expandable fixation structures
|
|
US8489189B2
(en)
*
|
2004-10-29 |
2013-07-16 |
Medtronic, Inc. |
Expandable fixation mechanism
|
|
US7937143B2
(en)
|
2004-11-02 |
2011-05-03 |
Ardian, Inc. |
Methods and apparatus for inducing controlled renal neuromodulation
|
|
US9358393B1
(en)
|
2004-11-09 |
2016-06-07 |
Andres M. Lozano |
Stimulation methods and systems for treating an auditory dysfunction
|
|
US7483746B2
(en)
*
|
2004-12-06 |
2009-01-27 |
Boston Scientific Neuromodulation Corp. |
Stimulation of the stomach in response to sensed parameters to treat obesity
|
|
US9327069B2
(en)
|
2004-12-21 |
2016-05-03 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a medical condition by promoting neural remodeling within the brain
|
|
US20060161217A1
(en)
*
|
2004-12-21 |
2006-07-20 |
Jaax Kristen N |
Methods and systems for treating obesity
|
|
US20070038264A1
(en)
*
|
2004-12-21 |
2007-02-15 |
Jaax Kristen N |
Methods and systems for treating autism
|
|
US9095713B2
(en)
*
|
2004-12-21 |
2015-08-04 |
Allison M. Foster |
Methods and systems for treating autism by decreasing neural activity within the brain
|
|
US8515541B1
(en)
|
2004-12-22 |
2013-08-20 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating post-stroke disorders
|
|
US9352145B2
(en)
*
|
2004-12-22 |
2016-05-31 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a psychotic disorder
|
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
|
CA2593244C
(en)
*
|
2005-01-06 |
2013-08-20 |
Oy Halton Group, Ltd |
Automatic displacement ventilation system with heating mode
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US7853321B2
(en)
*
|
2005-03-14 |
2010-12-14 |
Boston Scientific Neuromodulation Corporation |
Stimulation of a stimulation site within the neck or head
|
|
US7848803B1
(en)
|
2005-03-14 |
2010-12-07 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
|
US8423155B1
(en)
|
2005-03-14 |
2013-04-16 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
|
US7702385B2
(en)
*
|
2005-11-16 |
2010-04-20 |
Boston Scientific Neuromodulation Corporation |
Electrode contact configurations for an implantable stimulator
|
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
US8067399B2
(en)
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
|
US20070027105A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US7684858B2
(en)
*
|
2005-09-21 |
2010-03-23 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for placing an implanted stimulator for stimulating tissue
|
|
AU2006315601A1
(en)
|
2005-11-14 |
2007-05-24 |
Enterprise Partners Venture Capital |
Stem cell factor therapy for tissue injury
|
|
US7729758B2
(en)
*
|
2005-11-30 |
2010-06-01 |
Boston Scientific Neuromodulation Corporation |
Magnetically coupled microstimulators
|
|
US7610100B2
(en)
*
|
2005-12-30 |
2009-10-27 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating osteoarthritis
|
|
US7835803B1
(en)
*
|
2006-01-17 |
2010-11-16 |
Boston Scientific Neuromodulation Corporation |
Lead assemblies with one or more switching networks
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
US8175710B2
(en)
*
|
2006-03-14 |
2012-05-08 |
Boston Scientific Neuromodulation Corporation |
Stimulator system with electrode array and the method of making the same
|
|
US7777641B2
(en)
*
|
2006-03-29 |
2010-08-17 |
Advanced Bionics, Llc |
Systems and methods of facilitating communication between a first and second device
|
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
US20070275035A1
(en)
*
|
2006-05-24 |
2007-11-29 |
Microchips, Inc. |
Minimally Invasive Medical Implant Devices for Controlled Drug Delivery
|
|
CA2651855C
(en)
|
2006-05-30 |
2011-08-02 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8504163B1
(en)
|
2006-06-30 |
2013-08-06 |
Boston Scientific Neuromodulation Corporation |
Cranially mounted stimulation systems and methods
|
|
US8401654B1
(en)
|
2006-06-30 |
2013-03-19 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating one or more effects of deafferentation
|
|
WO2008021133A2
(en)
|
2006-08-09 |
2008-02-21 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
US20080131398A1
(en)
*
|
2006-08-21 |
2008-06-05 |
United Therapeutics Corporation |
Combination therapy for treatment of viral infections
|
|
US7445528B1
(en)
|
2006-09-29 |
2008-11-04 |
Boston Scientific Neuromodulation Corporation |
Connector assemblies
|
|
US7347746B1
(en)
|
2006-10-27 |
2008-03-25 |
Boston Scientific Neuromodulation Corporation |
Receptacle connector assembly
|
|
US20080103576A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Medtronic, Inc. |
Implantable medical elongated member including expandable fixation member
|
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
|
US20090259217A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems associated with delivery of one or more agents to an individual
|
|
US20090259215A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems associated with delivery of one or more agents to an individual
|
|
EP3025727A1
(en)
|
2008-10-02 |
2016-06-01 |
The J. David Gladstone Institutes |
Methods of treating liver disease
|
|
TW201035111A
(en)
|
2008-12-23 |
2010-10-01 |
Biosource Pharm Inc |
Antibiotic compositions for the treatment of gram negative infections
|
|
US8652129B2
(en)
|
2008-12-31 |
2014-02-18 |
Medtronic Ardian Luxembourg S.A.R.L. |
Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
|
|
JP2012520884A
(ja)
|
2009-03-18 |
2012-09-10 |
ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー |
フラビウイルス科ウイルス感染症を治療する方法および組成物
|
|
LT2462246T
(lt)
|
2009-09-28 |
2017-11-27 |
Intarcia Therapeutics, Inc |
Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
|
|
US8882748B2
(en)
*
|
2009-10-08 |
2014-11-11 |
Palo Alto Research Center Incorporated |
Transmucosal drug delivery device and method including chemical permeation enhancers
|
|
US9017310B2
(en)
*
|
2009-10-08 |
2015-04-28 |
Palo Alto Research Center Incorporated |
Transmucosal drug delivery device and method including microneedles
|
|
US9014799B2
(en)
*
|
2009-10-08 |
2015-04-21 |
Palo Alto Research Center Incorporated |
Transmucosal drug delivery device and method including electrically-actuated permeation enhancement
|
|
US8415307B1
(en)
|
2010-06-23 |
2013-04-09 |
Biosource Pharm, Inc. |
Antibiotic compositions for the treatment of gram negative infections
|
|
TWI513451B
(zh)
|
2010-10-25 |
2015-12-21 |
美敦力阿迪恩盧森堡公司 |
用於神經調節治療之估算及反饋的裝置、系統及方法
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
WO2012175698A1
(en)
|
2011-06-23 |
2012-12-27 |
Université Libre de Bruxelles |
Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
|
|
EP2751291B1
(en)
|
2011-09-01 |
2018-08-15 |
University of Southern California |
Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same
|
|
CN104066432B
(zh)
|
2011-12-06 |
2017-06-13 |
小利兰·斯坦福大学董事会 |
用于治疗病毒性疾病的方法和组合物
|
|
US8979885B2
(en)
|
2012-02-24 |
2015-03-17 |
Elwha Llc |
Devices, systems, and methods to control stomach volume
|
|
WO2013134548A2
(en)
|
2012-03-08 |
2013-09-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Ovarian neuromodulation and associated systems and methods
|
|
WO2013134733A2
(en)
|
2012-03-08 |
2013-09-12 |
Medtronic Ardian Luxembourg Sarl |
Biomarker sampling in the context of neuromodulation devices and associated systems and methods
|
|
US9999720B2
(en)
|
2012-09-27 |
2018-06-19 |
Palo Alto Research Center Incorporated |
Drug reconstitution and delivery device and methods
|
|
US9005108B2
(en)
|
2012-09-27 |
2015-04-14 |
Palo Alto Research Center Incorporated |
Multiple reservoir drug delivery device and methods
|
|
US20140110296A1
(en)
|
2012-10-19 |
2014-04-24 |
Medtronic Ardian Luxembourg S.A.R.L. |
Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
|
|
US9744341B2
(en)
|
2013-01-15 |
2017-08-29 |
Palo Alto Research Center Incorporated |
Devices and methods for intraluminal retention and drug delivery
|
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
|
US9297083B2
(en)
|
2013-12-16 |
2016-03-29 |
Palo Alto Research Center Incorporated |
Electrolytic gas generating devices, actuators, and methods
|
|
US10194979B1
(en)
|
2014-03-28 |
2019-02-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for catheter-based renal neuromodulation
|
|
US10194980B1
(en)
|
2014-03-28 |
2019-02-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for catheter-based renal neuromodulation
|
|
US9980766B1
(en)
|
2014-03-28 |
2018-05-29 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and systems for renal neuromodulation
|
|
US9801660B2
(en)
|
2014-07-31 |
2017-10-31 |
Palo Alto Research Center Incorporated |
Implantable fluid delivery devices, systems, and methods
|
|
US10278675B2
(en)
|
2014-07-31 |
2019-05-07 |
Palo Alto Research Center Incorporated |
Implantable estrus detection devices, systems, and methods
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US20180104251A1
(en)
|
2015-03-09 |
2018-04-19 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for the treatment of glioblastoma
|
|
CA2987766A1
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
JP2018528763A
(ja)
|
2015-07-31 |
2018-10-04 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
バイオフィルムの除去のためのペプチドおよび抗体
|
|
EP3365027B1
(en)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu specific antibodies and their use in inhibiting biofilm
|
|
US10501517B2
(en)
|
2016-05-16 |
2019-12-10 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
|
US12098188B2
(en)
|
2017-01-04 |
2024-09-24 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Ｄｎａｂｉｉワクチンおよび強化された活性を有する抗体
|
|
KR102018421B1
(ko)
|
2017-05-17 |
2019-09-04 |
김은형 |
두상 교정 장치
|
|
WO2019130828A1
(ja)
*
|
2017-12-27 |
2019-07-04 |
富士フイルム株式会社 |
包装材およびその使用方法
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
WO2021007260A2
(en)
|
2019-07-08 |
2021-01-14 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
|
CA3203561A1
(en)
|
2021-01-12 |
2022-07-21 |
Adrian Neil Verity |
Sustained release drug delivery systems and related methods
|